PERSONENI, Nicola

PERSONENI, Nicola  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 84 (tempo di esecuzione: 0.052 secondi).
Titolo Data di pubblicazione Autore(i) File
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study 1-gen-2015 Santoro, A; Gebbia, V; Pressiani, T; Testa, A; Personeni, N; Bajardi, Ea; Foa, P; Buonadonna, A; Bencardino, K; Barone, C; Ferrari, D; Zaniboni, A; Tronconi, Mc; Carteni, G; Milella, M; Comandone, A; Ferrari, S; Rimassa, L
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma 1-gen-2010 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? 1-gen-2011 Personeni, N.; Torzilli, G.; Santoro, A.
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 1-gen-2018 Vigano, L; Pedicini, V; Comito, T; Carnaghi, C; Costa, G; Poretti, D; Franzese, C; Personeni, N; Del Fabbro, D; Rimassa, L; Scorsetti, M; Santoro, A; Solbiati, L; Torzilli, G
Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner 1-gen-2020 Campani, Claudia; Rimassa, Lorenza; Personeni, Nicola; Marra, Fabio
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma 1-gen-2021 Jun, Tomi; Ozbek, Umut; Dharmapuri, Sirish; Hardy-Abeloos, Camille; Zhu, Huili; Lin, Jung-Yi; Personeni, Nicola; Pressiani, Tiziana; Nishida, Naoshi; Lee, Pei-Chang; Lee, Chieh-Ju; Hildebrand, Hannah; Nimkar, Neil; Paul, Sonal; Fessas, Petros; Naeem, Muntaha; Bettinger, Dominik; Khan, Uqba; Saeed, Anwaar; Huang, Yi-Hsiang; Kudo, Masatoshi; Rimassa, Lorenza; Marron, Thomas U; Pinato, David J; Ang, Celina
Are we ready for patient-reported outcomes in hepatocellular carcinoma? 1-gen-2021 Personeni, Nicola; Rimassa, Lorenza
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications 1-gen-2016 Personeni, N; Baretti, M; Bozzarelli, S; Spaggiari, P; Rubino, L; Tronconi, Mc; Fumagalli, U; Rosati, R; Giordano, L; Roncalli, M; Santoro, A; Rimassa, L
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma 1-gen-2021 D'Alessio, Antonio; Cammarota, Antonella; Zanuso, Valentina; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 1-gen-2020 Personeni, Nicola; Lleo, Ana; Pressiani, Tiziana; Colapietro, Francesca; Openshaw, Mark Robert; Stavraka, Chara; Pouptsis, Athanasios; Pinato, David James; Rimassa, Lorenza
Biomarkers in Hepatocellular Carcinoma-Letter 1-gen-2012 Personeni, N; Rimassa, L; Santoro, A
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer 1-gen-2019 Mennini, Fs; Marcellusi, A; Fabiano, G; Rimassa, L; Santoro, A; Personeni, N
Cabozantinib for the treatment of hepatocellular carcinoma 1-gen-2019 Personeni, N; Rimassa, L; Pressiani, T; Smiroldo, V; Santoro, A
Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib 1-gen-2019 Personeni, N; Pressiani, T; Rimassa, L
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials 1-gen-2022 Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 1-gen-2016 Comito, T; Cozzi, L; Clerici, E; Franzese, C; Tozzi, A; Iftode, C; Navarria, P; D’Agostino, G; Rimassa, L; Carnaghi, C; Personeni, N; Tronconi, Mc; De Rose, F; Franceschini, D; Ascolese, Am; Fogliata, A; Tomatis, S; Santoro, A; Zerbi, A; Scorsetti, M
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 1-gen-2017 Comito, T; Cozzi, L; Zerbi, A; Franzese, C; Clerici, E; Tozzi, A; Iftode, C; Navarria, P; D'Agostino, G; Fogliata, A; Mancosu, P; Tomatis, S; Carnaghi, C; Personeni, N; Santoro, A; Scorsetti, M
COVID-19 and liver cancer clinical trials: not everything is lost 1-gen-2020 D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma 1-gen-2018 Mazzaferro, V; El-Rayes, Bf; Droz Dit Busset, M; Cotsoglou, C; Harris, Wp; Damjanov, N; Masi, G; Rimassa, L; Personeni, N; Braiteh, F; Zagonel, V; Papadopoulos, Kp; Hall, T; Wang, Y; Schwartz, B; Kazakin, J; Bhoori, S; de Braud, F; Shaib, Wl
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 1-gen-2015 Lopci, E; Torzilli, G; Poretti, D; de Neto, Ljs; Donadon, M; Rimassa, L; Lanza, E; Sabongi, Jg; Ceriani, R; Personeni, N; Palmisano, A; Pedicini, V; Comito, T; Scorsetti, M; Chiti, A